Icatibant
NDC 46708-654, Icatibant, injection, from Alembic Pharmaceuticals Limited.
- Product NDC
- 46708-654
- Status
- Listed
- Labeler
- Alembic Pharmaceuticals Limited
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213773
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/46708-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ICATIBANT ACETATE30 mg/3mL
Pharmacologic classes
Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 46708-654-03 | 46708065403 | 1 SYRINGE, GLASS in 1 CARTON (46708-654-03) / 3 mL in 1 SYRINGE, GLASS |
| 46708-654-09 | 46708065409 | 3 SYRINGE, GLASS in 1 CARTON (46708-654-09) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8c149392-d281-4311-880f-3be2b4752f40
Use it
Look up 46708-654 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/46708-654 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 46708-654. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.